[Outpatient polyclinic observations on senzit in the treatment of ischemic heart disease].
56 patients, aged from 28 up to 60 years, with ischemic heart disease II-III functional class according to the Canadian classification were treated with the original Hungarian drug Sensit in out-patient conditions. The number of patients with anginal pain fell from 56 to 12 and the overall effect of the Sensit treatment was 84% (47 patients improved). The physical load tolerance significantly increased--from 58.2 to 67.4 W. Sensit influences the pathological ECG changes--ST segment lowering after physical load. It must be emphasized that the effect of the Sensit treatment is seen after a 3 week course of treatment at least. The drug is suitable for an out-patient treatment.
A
A
Kokutsov
D000328:Adult; D000553:Ambulatory Care; D000787:Angina Pectoris / Q000188:drug therapy / Q000503:physiopathology; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D005275:Fendiline / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use*; D010807:Physical Endurance / Q000187:drug effects
D010627:Phenethylamines; D005275:Fendiline
Ambulatorno-poliklinichni nabliudeniia vŭrkhu senzit pri lechenie na iskhemichna bolest na sŭrtseto.